Federation Des Caisses Desjardins Du Quebec Editas Medicine, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$23.7 Billion
Q3 2025

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 5,500 shares of EDIT stock, worth $14,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,500

Previous 5,500 -0.0%

Holding current value

$14,300

Previous $12,000 58.33%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.14 - $3.2 $5,699 - $16,000	5,000 Added 1000.0%	5,500 $6,000
Q4 2024 Feb 13, 2025	SELL	$1.2 - $3.76 $60 - $188	-50 Reduced 9.09%	500 $0
Q3 2024 Nov 13, 2024	BUY	$3.39 - $5.96 $169 - $298	50 Added 10.0%	550 $1,000
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $3,515 - $5,535	500 New	500 $3.71 Million
Q3 2022 Aug 14, 2024	SELL	$12.16 - $19.42 $3,648 - $5,826	-300 Reduced 30.0%	700 $8.57 Million

Q2 2022 Aug 14, 2024	SELL	$9.99 - $21.35 $999 - $2,135	-100 Reduced 9.09%	1,000 $11.8 Million
Q1 2022 Aug 14, 2024	BUY	$14.08 - $27.63 $8,448 - $16,578	600 Added 120.0%	1,100 $20.9 Million
Q4 2021 Aug 30, 2024	SELL	$26.55 - $40.57 $5,310 - $8,114	-200 Reduced 15.38%	1,100 $29.2 Million
Q3 2021 Aug 30, 2024	BUY	$39.27 - $72.94 $1,963 - $3,647	50 Added 4.0%	1,300 $53.4 Million
Q2 2021 Aug 30, 2024	BUY	$31.29 - $56.64 $23,467 - $42,480	750 Added 150.0%	1,250 $70.8 Million
Q1 2021 Aug 30, 2024	BUY	$39.71 - $90.58 $22,436 - $51,177	565 Added 55.39%	1,585 $66.6 Million
Q4 2020 Aug 30, 2024	BUY	$27.07 - $84.35 $22,197 - $69,167	820 Added 410.0%	1,020 $71.5 Million
Q3 2020 Aug 30, 2024	SELL	$28.06 - $37.16 $2,806 - $3,715	-100 Reduced 33.33%	200 $5.61 Million
Q4 2019 Aug 30, 2024	BUY	$19.49 - $32.63 $1,948 - $3,263	100 Added 50.0%	300 $8.88 Million
Q2 2019 Aug 30, 2024	SELL	$20.48 - $27.76 $6,144 - $8,328	-300 Reduced 60.0%	200 $4.95 Million

Others Institutions Holding EDIT

# of Institutions

228

Shares Held

46.2M

Call Options Held

841K

Put Options Held

304K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $179M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Editas Medicine, Inc. Transaction History